NetScientific (NSCI)

Sector:

Financials

67.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 81.00
  • 52 Week Low: 49.00
  • Currency: UK Pounds
  • Shares Issued: 23.95m
  • Volume: 2,236
  • Market Cap: £16.04m
  • RiskGrade: 410

NetScientific portfolio company Axsis bags first sale

By Duncan Ferris

Date: Thursday 15 Feb 2018

LONDON (ShareCast) - (ShareCast News) - NetScientific announced on Thursday that its portfolio company, ProAxsis, has secured the first sale of NEATstik to a research laboratory conducting a respiratory clinical trial.
The product, which was registered with a CE mark in late 2017, utilises the company's ProteaseTag technology to allow the qualitative measurement of the active form of neutrophil elastase, an established biomarker of lung infection and inflammation.

Francois Martelet, chief executive of NetScientific, said: "We are very pleased to note the first sale of the NEATstik, which represents a significant milestone for ProAxsis as it begins to commercialize. We are also very pleased with the sales performance of the Neutrophil Elastase Immunoassay (NEIA) product."

NetScientific holds a 57% stake in ProAxsis, which develops products to capture, detect and measure active protease biomarkers of diseases.

"We believe ProAxsis maintains a competitive advantage through its ProteaseTag technology. We continue to expect ProAxsis will be able to generate over £1m in revenue for 2018," said Martelet.

Chief executive of ProAxsis David Ribeiro echoed Martelet's optimism, hailing a "very positive start to the year" and confirming that the company plans to expand their portfolio of commercial products.

As of 1047 GMT, NetScientific's shares were up 6.06% to 57.80p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

NetScientific Market Data

Currency UK Pounds
Share Price 67.00p
Change Today -2.00p
% Change -2.90 %
52 Week High 81.00
52 Week Low 49.00
Volume 2,236
Shares Issued 23.95m
Market Cap £16.04m
RiskGrade 410

NetScientific Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
37.43% above the market average37.43% above the market average37.43% above the market average37.43% above the market average37.43% above the market average
12.38% above the sector average12.38% above the sector average12.38% above the sector average12.38% above the sector average12.38% above the sector average
Price Trend
41.37% above the market average41.37% above the market average41.37% above the market average41.37% above the market average41.37% above the market average
31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average
Income Not Available
Growth
51.81% above the market average51.81% above the market average51.81% above the market average51.81% above the market average51.81% above the market average
53.70% above the sector average53.70% above the sector average53.70% above the sector average53.70% above the sector average53.70% above the sector average

NetScientific Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
09:03 2,000 @ 69.20p
09:00 2 @ 65.00p
09:00 2 @ 65.00p
08:46 234 @ 68.22p

NetScientific Key Personnel

CEO Ilian Iliev
CFO Stephen Crowe

Top of Page